Frances Pappas

3.0k total citations · 2 hit papers
16 papers, 2.2k citations indexed

About

Frances Pappas is a scholar working on Urology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Frances Pappas has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Urology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Frances Pappas's work include Urinary Bladder and Prostate Research (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Hormonal and reproductive studies (4 papers). Frances Pappas is often cited by papers focused on Urinary Bladder and Prostate Research (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Hormonal and reproductive studies (4 papers). Frances Pappas collaborates with scholars based in United States, Canada and Austria. Frances Pappas's co-authors include John D. McConnell, Julianne Imperato‐McGinley, Bruce Bracken, Jack Geller, Elizabeth Stoner, Gerald L. Andriole, Reginald C. Bruskewitz, Bruce Binkowitz, Glenn J. Gormley and Joyce S. Tenover and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Frances Pappas

16 papers receiving 2.1k citations

Hit Papers

The Effect of Finasteride in Men with Benign Prostatic Hy... 1992 2026 2003 2014 1992 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances Pappas United States 13 1.2k 857 707 381 372 16 2.2k
Marcelo Chen Taiwan 18 107 0.1× 253 0.3× 39 0.1× 141 0.4× 255 0.7× 95 1.1k
Vincenzo Favilla Italy 25 496 0.4× 396 0.5× 403 0.6× 216 0.6× 3 0.0× 71 1.4k
Ronald Smulders Netherlands 21 131 0.1× 77 0.1× 302 0.4× 95 0.2× 16 0.0× 36 1.1k
Jinze Li China 16 102 0.1× 212 0.2× 92 0.1× 67 0.2× 9 0.0× 83 952
Robert R. LaBadie United States 21 17 0.0× 171 0.2× 55 0.1× 47 0.1× 211 0.6× 51 1.0k
Uttam Sharma India 18 42 0.0× 104 0.1× 59 0.1× 27 0.1× 34 0.1× 90 1.2k
G. M. Murphy United Kingdom 26 11 0.0× 465 0.5× 178 0.3× 52 0.1× 22 0.1× 65 1.8k
Hakan Kültürsay Türkiye 22 20 0.0× 133 0.2× 68 0.1× 74 0.2× 34 0.1× 86 1.6k
Kesavan Esuvaranathan Singapore 22 160 0.1× 304 0.4× 20 0.0× 50 0.1× 28 0.1× 64 1.3k
Moohi Yoo South Korea 17 69 0.1× 29 0.0× 258 0.4× 13 0.0× 30 0.1× 43 750

Countries citing papers authored by Frances Pappas

Since Specialization
Citations

This map shows the geographic impact of Frances Pappas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Pappas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Pappas more than expected).

Fields of papers citing papers by Frances Pappas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Pappas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Pappas. The network helps show where Frances Pappas may publish in the future.

Co-authorship network of co-authors of Frances Pappas

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Pappas. A scholar is included among the top collaborators of Frances Pappas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Pappas. Frances Pappas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zou, Yuanxi, Jerry Nedelman, Antonio Lombardi, et al.. (2022). Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling. Clinical Pharmacokinetics. 61(11). 1585–1593. 1 indexed citations
2.
Diacon, Andreas H., Veronique de Jager, Rodney Dawson, et al.. (2020). Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy. 64(4). 23 indexed citations
3.
Gillespie, Stephen H., Angela M. Crook, Timothy D. McHugh, et al.. (2014). Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis. New England Journal of Medicine. 371(17). 1577–1587. 401 indexed citations breakdown →
4.
Lowe, Franklin C., John D. McConnell, Perry B. Hudson, et al.. (2003). Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia. Urology. 61(4). 791–796. 75 indexed citations
5.
VAUGHAN, D. E., Julianne Imperato‐McGinley, John D. McConnell, et al.. (2002). Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology. 60(6). 1040–1044. 57 indexed citations
6.
Stoner, Elizabeth, Reginald C. Bruskewitz, Julianne Imperato‐McGinley, et al.. (2002). The effect of finasteride in men with benign prostatic hyperplasia. The Journal of Urology. 167(2 Part 2). 1102–1107. 31 indexed citations
7.
Kaplan, Steven A., Patricia Gilhooly, Richard F. Labasky, et al.. (2000). Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. Urology. 56(4). 610–616. 46 indexed citations
8.
Price, Vera H., Janet L. Roberts, Maria Hordinsky, et al.. (2000). Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Journal of the American Academy of Dermatology. 43(5). 768–776. 197 indexed citations
9.
Marberger, Michael, Jay Andersen, J. Curtis Nickel, et al.. (2000). Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention. European Urology. 38(5). 563–568. 95 indexed citations
10.
Moore, E. Colleen, Bruce Bracken, William J. Bremner, et al.. (1995). Proscar®: Five-Year Experience. European Urology. 28(4). 304–309. 52 indexed citations
11.
Gormley, Glenn J., Elizabeth Stoner, Reginald C. Bruskewitz, et al.. (1992). The Effect of Finasteride in Men with Benign Prostatic Hyperplasia. New England Journal of Medicine. 327(17). 1185–1191. 895 indexed citations breakdown →
12.
Beisland, Hans Olav, Bruce Binkowitz, Peter Ekman, et al.. (1992). Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia. European Urology. 22(4). 271–277. 37 indexed citations
13.
McConnell, John D., J D Wilson, Fredrick W. George, et al.. (1992). Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.. The Journal of Clinical Endocrinology & Metabolism. 74(3). 505–508. 264 indexed citations
14.
Willis, John, et al.. (1989). SOMATOSENSORY EVOKED POTENTIALS PREDICT NEUROMOTOR OUTCOME AFTER PERIVENTRICULAR HEMORRHAGE. Developmental Medicine & Child Neurology. 31(4). 435–439. 27 indexed citations
15.
Pappas, Frances, et al.. (1987). Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.. PubMed. 52. 32–9. 4 indexed citations
16.
Pappas, Frances, et al.. (1986). Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy. Journal of Antimicrobial Chemotherapy. 18(Supplement_E). 185–191. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026